Skip to main content

Elms Steve's Form 4 filing

Elevation Oncology, Inc. · filed Jul 1, 2021

Accession no.
0001209191-21-044561
Filed
Jul 1, 2021, 6:29 PM ET
Trade date
Jun 29, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $3.00M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Elms SteveCIK 0001250195Director, Other: Managing Member
Schiff Andrew NCIK 0001172252Other: Managing Member
Aisling Capital IV, LPCIK 000165291010% Owner
Aisling Capital Partners IV LLCCIK 000173701910% Owner
Aisling Capital Partners IV, LPCIK 000173702010% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 29, 2021Common StockCConversionAcquired+1,893,232$0.00F1$02,189,050Direct
Jun 29, 2021Common StockCConversionAcquired+458,360$0.00F1$02,647,410Direct
Jun 29, 2021Common StockPPurchaseAcquired+187,500$16.00+$3,000,0002,834,910Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 29, 2021Common StockCConversionDisposed−1,893,232$0.00$00Direct
Jun 29, 2021Common StockCConversionDisposed−458,360$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)